Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related TEVA
Teva, Heptares Announce Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine
Benzinga's Top Upgrades
Ad Comm approaches for Fabre-Kramer's MDD med (Seeking Alpha)
Related JASO
Earnings Scheduled For November 17, 2015
For The Patient Investor, Future Looks Bright For Solar ETFs
JA Solar Continues To Outperform (Seeking Alpha)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

Nov 2015Goldman SachsUpgradesNeutralBuy
Sep 2015NomuraInitiates Coverage onNeutral
Aug 2015Goldman SachsReinstatesBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (INDB + JASO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters